Soligenix, a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, ...
Tags: Soligenix, NIAID, ThermoVax, Drs.John Carpenter
Pfenex has received a subcontract from Leidos Holdings (LDOS) to support the development of an anthrax vaccine containing its recombinant protective antigen (rPA) and a novel, immune-enhancing adjuvant. The initial contract was awarded by ...
Tags: Pfenex, Anthrax Vaccine
PharmAthene, a biodefense company, announced that it has terminated its definitive merger agreement with US-based Theraclone Sciences with consent from Theraclone. The agreement provided for the merger of a wholly-owned subsidiary of ...
Fraunhofer Center for Molecular Biotechnology (FhCMB) has received a contract from the US National Institute of Allergy and Infectious Diseases to develop vaccine technologies for advancing the next generation of anthrax vaccines. ...
Tags: FhCMB, anthrax vaccines, NIH
Emergent BioSolutions has received FDA approval for its supplemental Biologics License Application (sBLA) to change the administration schedule of BioThrax to a three-dose primary series of intramuscular injections at zero, one, and six ...
Tags: Medicine, Emergent BioSolutions, Anthrax Vaccine Adsorbed